IP Library Granted Patent US 9,044,397
Granted Patent B2
US 9,044,397 · App. 13/937,363 · Granted Jun 2, 2015

Medical devices with galvanic particulates

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,044,397
App. No.
13/937,363
Granted
Jun 2, 2015
Kind
B2
Abstract

Implantable medical devices having galvanic particulates are disclosed. The particulate may be coated onto at least part of a surface of the medical device. In addition, the galvanic particulates may be contained in the material used to manufacture the antimicrobial medical devices, or may be embedded into the surface of the medical devices. The present invention also provides novel coating methods and processing methods. The present invention further provides a combination of galvanic particulates with an aqueous gel, a method of making this combination, and a method of treatment using this combination. The devices and compositions may have advantageous characteristics and effects including anti-microbial, anti-inflammatory, tissue regeneration promoting, and pain reduction or elimination.

Claims (5)

1. A method of relieving joint pain in the arthritic condition comprising the steps of providing a composition comprising a galvanic particulate and an aqueous gel, and delivering the composition into a joint, wherein the aqueous gel comprises a carboxylmethylcellulose

wherein the galvanic particulate comprises a first conductive material and a second conductive material, wherein both said first conductive material and said second conductive material have surfaces which are at least partially exposed, wherein the particle size of said particulate is from about 10 nanometers to about 100 micrometers, wherein the second conductive material comprises from about 0.01 percent to about 10 percent, by weight, of the total weight of said particulate, and wherein the difference of the standard potentials of the first conductive material and the second conductive material is at least about 0.2 V, and

wherein the composition comprises 0.25 mg/ml to 1 mg/ml carboxymethylcellulose.

2. The method of claim 1 wherein the first conductive material is selected from the group consisting of zinc and magnesium, and the second conductive material is selected from the group consisting of copper and silver.

3. The method of claim 1 wherein delivering the composition into a joint consists of injecting the composition intra-articularly into the joint.